A Training Software (SJ-RS-WL2015) Rehabilitating Intermittent Exotropia Binocular Functions

February 7, 2020 updated by: Guangzhou Shijing Medical Software

A Phase 4 Randomized, Single-blind Study to Evaluate the Multi-media Training(SJ-RS-WL2015)Software Rehabilitating Ability of Binocular Functions in Hospitalized Adolescent Patients With Intermittent Exotropia After Eye Surgery

Evaluating the effect of SJ-RS-WL2015 visual training program in children with intermittent exotropia after eye surgery, including the improvement of simultaneous perception (I binocular function), fusion (II binocular function), stereopsis (III binocular function).

Study Overview

Status

Unknown

Detailed Description

All the patients are after eye surgery for intermittent exotropia. All the participants with 20/20 or better visual acuity.

Study Type

Interventional

Enrollment (Actual)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Guangdong
      • Guangzhou, Guangdong, China, 510000
        • Guangzhou Shijing Medical Software Co., Ltd.
      • Guanzhou, Guangdong, China, 510000
        • Zhongshan Ophthalmic Center, Sun Yat-sen University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of Intermittent Exotropia
  • Must be after eye surgery for Intermittent Exotropia
  • Baseline Deviation Range: Esotropia<=5△ or Exotropia<15△ after Eye Surgery
  • Visual Acuity: >=20/20

Exclusion Criteria:

  • A-V patterns deviations
  • Abnormal oblique or vertical rectus
  • Nystagmus
  • Ophthalmoplegia
  • Anisometropia >2.5D
  • With other eye surgery history
  • Mental disorder
  • Neural disease
  • Tumor
  • Heart disease
  • Hypertension
  • Epilepsy
  • Severe systemic disease
  • With vision therapy history within 4 weeks
  • Implanted electronic device
  • In other researches within 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group with SJ-RS-WL2015
Item code: SJ-RS-WL2015, a visual training software program, 15 minutes of one section, twice a day, and for 1 year
It is a software with perceptual learning methods for binocular functions
Other Names:
  • SJ-RS-WL2015 visual training program
No Intervention: control group
No special treatment, but observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline Stereopsis at 12 months
Time Frame: 12 months
Measured with Synoptophore and Titmus stereo test, respectively
12 months
Change from Baseline Fusion at 12 months
Time Frame: 12 months
Measured with Worth 4-dot test and Synoptophore, respectively
12 months
Change from Baseline Simultaneous Perception at 12 months
Time Frame: 12 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
12 months
Change from Baseline Stereopsis at 6 months
Time Frame: 6 months
Measured with Synoptophore and Titmus stereo test, respectively
6 months
Change from Baseline Fusion at 6 months
Time Frame: 6 months
Measured with Worth 4-dot test and Synoptophore, respectively
6 months
Change from Baseline Simultaneous Perception at 6 months
Time Frame: 6 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
6 months
Change from Baseline Stereopsis at 3 months
Time Frame: 3 months
Measured with Synoptophore and Titmus stereo test, respectively
3 months
Change from Baseline Fusion at 3 months
Time Frame: 3 months
Measured with Worth 4-dot test and Synoptophore, respectively
3 months
Change from Baseline Simultaneous Perception at 3 months
Time Frame: 3 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
3 months
Change from Baseline Stereopsis at 2 months
Time Frame: 2 months
Measured with Synoptophore and Titmus stereo test, respectively
2 months
Change from Baseline Fusion at 2 months
Time Frame: 2 months
Measured with Worth 4-dot test and Synoptophore, respectively
2 months
Change from Baseline Simultaneous Perception at 2 months
Time Frame: 2 months
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore, respectively
2 months
Change from Baseline Stereopsis at 1 month
Time Frame: 1 month
Measured with Synoptophore and Titmus stereo test, respectively
1 month
Change from Baseline Fusion at 1 month
Time Frame: 1 month
Measured with Worth 4-dot test and Synoptophore, respectively
1 month
Change from Baseline Simultaneous Perception at 1 month
Time Frame: 1 month
Measured with Bagolini striated lens, Worth 4-dot test, and Synoptophore,
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual Acuity
Time Frame: one year
by LogMAR Visual Acuity Chart
one year
Change from Baseline Deviation Degree at 1 year
Time Frame: 1 year
by Prism Test
1 year
Change from Baseline Refractive Error at 1 year
Time Frame: 1 year
by Phoropter
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2019

Primary Completion (Anticipated)

October 31, 2020

Study Completion (Anticipated)

December 31, 2020

Study Registration Dates

First Submitted

February 6, 2020

First Submitted That Met QC Criteria

February 7, 2020

First Posted (Actual)

February 10, 2020

Study Record Updates

Last Update Posted (Actual)

February 10, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • GuangzhouShijingMS2020ITE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intermittent Exotropia

Clinical Trials on SJ-RS-WL2015 visual training program software

Subscribe